引用本文:朱晓峰.肝癌肝移植的研究进展与挑战[J].中国临床新医学,2020,13(12):1190-1193.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 73次   下载 69 本文二维码信息
码上扫一扫!
分享到: 微信 更多
肝癌肝移植的研究进展与挑战
朱晓峰
510080 广州,中山大学附属第一医院器官移植科
摘要:
[摘要]  肝移植是根治终末期肝病的有效手段之一,为肝癌患者提供了新的选择。然而,术后肿瘤复发、转移已成为影响肝移植疗效的最主要因素,是肝癌肝移植必须面临的挑战。该文就肝癌肝移植的适应证标准、候肝期治疗、免疫治疗、肿瘤监测、复发治疗进行述评,为肝癌肝移植的临床应用提供临床参考。
关键词:  肝癌  肝移植  复发  述评
DOI:10.3969/j.issn.1674-3806.2020.12.02
分类号:R 735.7;R 657.3
基金项目:国家“十一五”科技支撑计划资助项目(编号:2008BAl6B06);广东省科技计划资助项目(编号:2010B031600222)
Research progress and challenges of liver transplantation for hepatocellular carcinoma
ZHU Xiao-feng
Department of Organ Transplantation, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
Abstract:
[Abstract] Liver transplantation is one of the effective methods to radically cure end-stage liver disease, which provides a new choice for patients with hepatocellular carcinoma. However, postoperative tumor recurrence and metastasis has become the most important factor affecting the efficacy of liver transplantation, which is a challenge that liver transplantation must face. In this paper, we review the indication criteria, treatment in waiting for liver, immunotherapy, tumor monitoring and recurrence treatment of liver transplantation for hepatocellular carcinoma, providing clinical reference for clinical application of liver transplantation for hepatocellular carcinoma.
Key words:  Hepatocellular carcinoma  Liver transplantation  Recurrence  Review